All Stories

  1. Impact of Fucosylation on Self-Assembly of Prostate and Breast Tumor Spheroids by Using Cyclo-RGDfK(TPP) Peptide and Image Object Detection

    Article • OncoTargets and Therapy, December 2019, Taylor & Francis

    Sergey Burov, Myron Szewczuk

  2. The crucial role of primary care providers in the long-term follow-up of adult survivors of childhood cancer

    Article • Cancer Management and Research, April 2019, Dove Medical Press

    Myron Szewczuk

  3. Recent advances in "smart" delivery systems for extended drug release in cancer therapy

    Article • International Journal of Nanomedicine, August 2018, Dove Medical Press

    Myron Szewczuk

  4. Combinatorial and sequential delivery of gemcitabine and oseltamivir phosphate from implantable poly(D,L-lactic-co-glycolic acid) cylinders disables human pancreatic cancer cell survival

    Article • Drug Design Development and Therapy, July 2017, Dove Medical Press

    Myron Szewczuk

  5. Sialylation facilitates self-assembly of 3D multicellular prostaspheres by using cyclo-RGDfK(TPP) peptide

    Article • OncoTargets and Therapy, May 2017, Dove Medical Press

    Myron Szewczuk, Sergey Burov, Roman Akasov

  6. Alternative therapies for metastatic breast cancer: multimodal approach targeting tumor cell heterogeneity

    Article • Breast Cancer Targets and Therapy, February 2017, Dove Medical Press

    Myron Szewczuk

  7. Folic acid-conjugated amphiphilic alternating copolymer as a new active tumor targeting drug delivery platform

    Article • Drug Design Development and Therapy, December 2016, Dove Medical Press

    Myron Szewczuk

  8. Therapeutic designed poly (lactic-co-glycolic acid) cylindrical oseltamivir phosphate-loaded implants impede tumor neovascularization, growth and metastasis in mouse model of human pancreatic carcinoma

    Article • Drug Design Development and Therapy, August 2015, Dove Medical Press

    Myron Szewczuk

  9. Oseltamivir phosphate monotherapy ablates tumor neovascularization, growth, and metastasis in mouse model of human triple-negative breast adenocarcinoma

    Article • Breast Cancer Targets and Therapy, December 2014, Taylor & Francis

    Myron Szewczuk, Farah Alghamdi

  10. Therapeutic targeting of Neu1 sialidase with oseltamivir phosphate (Tamiflu®) disables cancer cell survival in human pancreatic cancer with acquired chemoresistance

    Article • OncoTargets and Therapy, January 2014, Taylor & Francis

    Myron Szewczuk, Dr. Myron R Szewczuk

  11. A novel G-protein-coupled receptor-signaling platform and its targeted translation in human disease

    Article • Research and Reports in Biochemistry, January 2013, Taylor & Francis

    Myron Szewczuk, Dr. Myron R Szewczuk